In addition, we could identify in the triterpene betulinic acid that originates from betulin, as one of the putative bioactive components of Chaga extract able to impair breast cancer cell viability and inhibit DHFR activity at micromolar concentrations. This evidence concerns the gene DHFR and breast carcinoma.